RethinkHIV released a Policy Brief based on a research paper by RethinkHIV researchers Michelle Remme, Charlotte Watts, and Anna Vassall.
The Policy Brief warns that an investment such as paying for girls’ schooling can fall through the gaps if we don’t look beyond HIV and take into account broader benefits to education and health.It argues that policy-makers need to stop taking a ‘silo’ approach to budgeting, where one sector’s gain is another sector’s loss.
Actions for Policy Makers
Support the co-financing of structural interventions that have HIV and other health or development benefits.
Be careful about ‘silo’ programming: design programmes to achieve multiple benefits.
Take into account both the costs and benefits of delivery across sectors.
Consider co-financing particularly for programmes with multiple outcomes across different sectors, but for which no sector alone is able to finance the full costs.
Questions for Policy Makers
What opportunities can you see for co-financing?
What are the impediments to co-financing in your country?
RethinkHIV is a consortium of senior researchers from London School of Hygiene & Tropical Medicine, Imperial College London, Harvard School of Public Health, Centre for the Study of African Economies and Blavatnik School of Government at Oxford University.
The consortium will evaluate new evidence related to the costs, benefits, effects, fiscal implications, and developmental impacts of HIV interventions in sub-Saharan Africa, in order to maximise contributions to the fight against HIV there.
The aim of RethinkHIV is to find ways of creating, optimising, and sustaining fiscal space for domestic HIV investment, as well as exploring long-term, sustainable national and international financing mechanisms. RethinkHIV is funded by RUSH Foundation.